or Try an Advanced Search...

    Overactive Bladder Stocks List

    Symbol Grade Name % Change
    MDT D Medtronic Inc. 0.75
    URGN F UroGen Pharma Ltd. 0.87
    View As Page of Charts
    Related Industries: Biotechnology Medical Devices
    Related Stock Lists: Medicine Ablation Ablation Products Advanced Energy Antineoplastic Drugs Atrial Fibrillation Biologic Product Biologic Products Biopharmaceutical Bladder Cancer Bone Botulinum Toxin Bypass Cancer Carcinoma Cardiac Electrophysiology Catheter Chemotherapy Chronic Pain Cordis

    Related ETFs - A few ETFs which own one or more of the above listed Overactive Bladder stocks.

    Symbol Grade Name Weight
    PCIG F Polen Capital International Growth ETF 5.31
    ABEQ B Absolute Core Strategy ETF 4.54
    IHI A iShares U.S. Medical Devices ETF 4.31
    CAMX A The Advisors? Inner Circle Fund Cambiar Aggressive Value ETF 4.21
    FLV A American Century Focused Large Cap Value ETF 3.91
    View all Overactive Bladder ETFs...
    Compare ETFs
    Compare ABEQ to FLV Compare CAMX to FLV Compare PCIG to FLV

        Overactive Bladder Stocks Recent News

        Date Stock Title
        Nov 21 MDT Healing People and Planet: 3 Things You Need to Know About This Shared Innovation Challenge
        Nov 21 MDT Here's Why Medtronic (MDT) is a Strong Value Stock
        Nov 21 MDT 3 Dividend Stocks I'll Never Sell
        Nov 21 MDT Medtronic’s insulin pen app gains FDA clearance
        Nov 20 MDT Medtronic plc (MDT): A Key Player in Ken Griffin’s Portfolio with Steady Growth
        Nov 20 MDT Medtronic reports rise in Q2 FY 2025 net income to $1.27bn
        Nov 20 MDT Healing People and Planet: New Impact Report Outlines How Medtronic Is Shaping the Future of Health
        Nov 20 MDT Medtronic receives FDA clearance for new InPen app
        Nov 20 MDT Medtronic receives FDA clearance for new InPen™ app, paving the way for its Smart MDI system launch with Simplera™ CGM
        Nov 20 MDT Jim Cramer on Medtronic plc (MDT): ‘It Has Been A Winner’
        Nov 20 MDT Medtronic Second Quarter 2025 Earnings: Beats Expectations
        Nov 20 MDT Medtronic PLC (MDT) Q2 2025 Earnings Call Highlights: Strong Revenue and EPS Growth Amid ...
        Nov 19 MDT Medtronic (MDT) Q2 2025 Earnings Call Transcript
        Nov 19 MDT Medtronic Q3 Earnings: A Solid Performance, But Bottom Line Still Needs Fixing
        Nov 19 MDT Medtronic Q2 Earnings: Diabetes And Neuroscience Revenue Boost Growth, Raises Annual Outlook
        Nov 19 MDT Medtronic's Stock Dips Despite Innovation Surge: What Investors Need to Know
        Nov 19 MDT Medtronic plc (MDT) Q2 2025 Earnings Call Transcript
        Nov 19 MDT Medtronic Flirts With A Sell Zone After Supplier Issue Trumps Beat And Raise
        Nov 19 MDT Medtronic Q2 Earnings and Revenues Top, Stock Down on Trimmed '25 View
        Nov 19 MDT Compared to Estimates, Medtronic (MDT) Q2 Earnings: A Look at Key Metrics
        Related Industries: Biotechnology Medical Devices
        Related Stock Lists: Medicine Ablation Ablation Products Advanced Energy Antineoplastic Drugs Atrial Fibrillation Biologic Product Biologic Products Biopharmaceutical Bladder Cancer Bone Botulinum Toxin Bypass Cancer Carcinoma Cardiac Electrophysiology Catheter Chemotherapy Chronic Pain Cordis
        Overactive Bladder

        Overactive bladder (OAB) is a condition in which the bladder muscles contract uncontrollably, causing a sudden and frequent urge to urinate. People with OAB may also experience urinary incontinence, or the inability to control the release of urine. OAB is a common condition that affects millions of people worldwide. Treatment options include lifestyle changes, medications, and in some cases, surgery.

        Browse All Tags